
Liked By
Spread the love. Be the first to like this post!
Recent SVA News
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 12/29/2022 01:41:47 PM
- SINOVAC Reports Unaudited First Half of 2022 Financial Results • Business Wire • 12/29/2022 01:30:00 PM
- Amended Statement of Beneficial Ownership (sc 13d/a) • Edgar (US Regulatory) • 12/12/2022 11:45:09 AM
- シノバックの水痘ワクチンがWHOの事前承認を取得 • Business Wire • 11/04/2022 12:01:00 PM
- Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k) • Edgar (US Regulatory) • 11/04/2022 11:48:08 AM
- Varizellen-Impfstoff von SINOVAC von WHO präqualifiziert • Business Wire • 11/04/2022 07:46:00 AM
- Le vaccin contre la varicelle de SINOVAC reçoit une préqualification de l'OMS • Business Wire • 11/04/2022 05:08:00 AM
- SINOVAC Varicella Vaccine Prequalified by WHO • Business Wire • 11/04/2022 02:03:00 AM
- シノバックがCPHIフランクフルトで製品を展示へ • Business Wire • 11/01/2022 12:08:00 PM
- SINOVAC va exposer ses produits à la CPHI de Francfort • Business Wire • 10/28/2022 06:08:00 PM
- SINOVAC stellt Produkte auf der CPHI Frankfurt vor • Business Wire • 10/28/2022 02:47:00 PM
- SINOVAC to Showcase Products at CPHI Frankfurt • Business Wire • 10/28/2022 09:00:00 AM
- シノバックのオミクロン株を含むCOVID-19ワクチンの臨床試験の開始がチリで承認される • Business Wire • 09/07/2022 11:57:00 AM
- SINOVAC erhält Genehmigung für klinische Studie zu seinem Omikron-COVID-19-Impfstoff in Chile • Business Wire • 09/06/2022 07:20:00 PM
- SINOVAC autorisé à lancer au Chili un essai clinique pour son vaccin contre le variant Omicron du Covid-19 • Business Wire • 09/06/2022 02:03:00 PM
- SINOVAC Approved to Initiate Clinical Trial for Its Omicron Containing COVID-19 Vaccine in Chile • Business Wire • 09/06/2022 10:00:00 AM
- シノバックのCOVID-19ワクチンが香港で生後6カ月以上の小児への使用が承認される • Business Wire • 08/05/2022 06:19:00 PM
- COVID-19-Impfstoff von SINOVAC in Hongkong zur Verwendung bei Kindern ab einem Alter von 6 Monaten zugelassen • Business Wire • 08/03/2022 04:45:00 PM
- L'utilisation du vaccin anti-COVID-19 de SINOVAC approuvée à partir de l'âge de six mois à Hong Kong • Business Wire • 08/03/2022 04:45:00 PM
- SINOVAC COVID-19 Vaccine Approved for Use in Children Above 6 months of Age in Hong Kong • Business Wire • 08/03/2022 10:00:00 AM
- シノバックがチリで4価インフルエンザワクチンの臨床試験を開始 • Business Wire • 07/20/2022 12:00:00 PM
- SINOVAC startet klinische Studie für seinen Vierfach-Grippeimpfstoff in Chile • Business Wire • 07/19/2022 01:31:00 PM
- SINOVAC lance un essai clinique au Chili pour son vaccin antigrippal quadrivalent • Business Wire • 07/19/2022 11:16:00 AM
- SINOVAC Initiates Clinical Trial for Its Quadrivalent Influenza Vaccine in Chile • Business Wire • 07/19/2022 05:30:00 AM
- シノバックのCOVID-19ワクチンがブラジルで3~5歳の小児への緊急使用承認を取得 • Business Wire • 07/18/2022 05:23:00 PM
1606 Corp Now Trading under Ticker CBDW, Management Announces First Acquisition • CBDW • Jan 27, 2023 11:59 AM
IQST - iQSTEL Reminds Shareholders To Get Their Votes In Before Annual Meeting Next Week On January 31, 2023 • IQST • Jan 26, 2023 9:53 AM
Nextech AR's AI-Powered CAD to Poly Toggle3D Launches Major Technology Advancements • ARWYF • Jan 26, 2023 8:46 AM
UCASU jump-starts its plan of NASDAQ or NYSE up-listing in 2023 • UCASU • Jan 26, 2023 7:21 AM
Kaya Holdings, Inc. (OTCQB: KAYS) Launches Fifth Dimension Therapeutics™ to seek to Provide Innovative Psychedelic-Based Treatments for Depression and Anxiety Related Conditions and Address the Growing Multi-Billion Dollar Global Psychedelics Market • KAYS • Jan 25, 2023 10:53 AM
B2 Digital's B2 SPORTS NETWORK (B2SN) Expands Distribution to Europe, Russia, and Asia with StayLIVE Agreement • BTDG • Jan 25, 2023 10:00 AM